Back and knee recovery device: A new approach in knee osteoarthritis patients

Introduction: Today, the most common pattern of multimorbidity among women and men is a combination of cardiometabolic and osteoarticular diseases, which is an example of the very common co-occurrence of type ۲ diabetes and osteoarthritis. In people with type ۲ diabetes, osteoarthritis often occurs simultaneously and has detrimental effects. Symptomatic osteoarthritis may also limit self-management of type ۲ diabetes through poor sleep. Therefore, the medical community has a duty to improve the disease in people with type ۲ diabetes by recognizing osteoarthritis and implementing evidence-based treatment for this disease. One of the interventions that can be used in this field is the use of a new adjuvant therapy called the 'Back and Knee Recovery Device (Kemerasa)' with the trade name (LKRD۲۰۰۰), which has been designed, manufactured, developed and patented in Iran. Methods: This study was a two-group clinical trial study that measured the effect of using the back and knee recovery device in patients with osteoarthritis grade ۱ and ۲ and diabetes type ۱ and ۲ on sleep quality and blood sugar levels of these patients. The intervention in question is the use of the 'Kemerasa' traction device. The study population included all patients with osteoarthritis grade ۱ and ۲ and diabetes type ۱ and ۲ simultaneously. The study samples were patients with osteoarthritis and diabetes who met the inclusion criteria. The intervention in question is the use of the back and knee recovery device (Back Recovery Device). Random allocation of samples was done by considering the entry criteria and through a lottery among those referring to the research environment (Emam Hospital Clinic). The number of intervention sessions was three times a week, each time for one hour, in addition to routine treatment. The demographic